Table 1 Recommended planning timeframes for various rhinologic surgeries during the COVID-19 era
Priority (Suggested Timeframe) | Surgical Procedure |
|---|---|
Emergent (<  24 h) | - Lesion or disease process (e.g. mucocele, infection, inflammatory, neoplastic, bleed) with significant acute neurologic or ophthalmologic compromise |
- Invasive fungal sinusitis | |
- Significant bleeding that cannot be managed by other means (e.g. packing, medical, interventional radiology) | |
Urgent (<  1 week) | - CSF leak repair (traumatic, iatrogenic) |
- Control of recurrent significant epistaxis (e.g. SPA ligation after failed nasal packing) | |
- Severely displaced or open fracture | |
Semi-Urgent (<  4 weeks) | - Biopsy of concerning nasal mass |
- Malignant sinonasal/skull base skull tumour resection | |
Expedited (<  3 months) | - Benign nasal tumour (ex. Juvenile nasopharyngeal angiofibroma, hemangioma, inverting papilloma) |
- Mycetoma | |
- Odontogenic sinusitis | |
- CSF leak repair (spontaneous) | |
Standard (Regular Waitlist) | - Endoscopic sinus surgery for CRS or mucocele (without neurologic or ophthalmologic compromise) |
- Other rhinologic procedures (e.g. septoplasty, septorhinoplasty, dacrocystorhinostomy, orbital decompression, functional nasal surgery) | |
- Skull base or orbital procedures for benign disease without neurologic compromise |